Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rom J Intern Med ; 59(4): 409-415, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34053203

RESUMO

Introduction. Information on healthcare-associated C.difficile infection (HA-CDI) in COVID-19 patients is limited. We aimed to assess the characteristics of HA-CDI acquired during and before the COVID-19 pandemic. Methods. We conducted a retrospective study in a tertiary care hospital, in which since March 2020 exclusively COVID-19 patients are hospitalized. We compared HA-CDI adult patients hospitalized in March 2020-February 2021 with those hospitalized during the same period in 2017-2018. Results. We found 51 cases during 2020-2021 (COVID-19 group), incidence 5.6/1000 adult discharge and 99 cases during 2017-2018 (pre-COVID-19 group), incidence 6.1/1000 adult discharge (p=0.6). The patients in COVID-19 group compared to pre-COVID-19 group were older (median age 66 vs 62 years), with similar rate of comorbidities, but with higher rate of cardiovascular diseases (62.7% vs 42.4%) and less immunosuppression (21.6% vs 55.6%), they had a higher proton pump inhibitors use (94.1% vs 32.3%), and a longer hospitalization (median 19 vs 14 days). Eighty-five (85.9%) patients in pre-COVID-19 group versus 44 (86.3%) patients in COVID-19 group received antimicrobial treatment - mainly cephalosporins (34,1%), quinolones (22,3%) and glycopeptides (21,1%) in pre-COVID-19 group and mainly cephalosporins and macrolides (63,6% each) in COVID-19 group. We found four HA-CDI-related deaths in pre-COVID-19 group and none in the COVID-19 group. Conclusions. The HA-CDI incidence in COVID-19 group did not change versus the same period of time during 2017-2018. The antibiotic use was the most important factor associated with HA-CDI. We identified a high use of broad-spectrum antibiotics despite the lack of empirical antimicrobial recommendations in COVID-19.


Assuntos
COVID-19 , Clostridioides difficile/isolamento & purificação , Infecções por Clostridium/epidemiologia , Infecção Hospitalar/epidemiologia , Adulto , Idoso , Antibacterianos/uso terapêutico , Anti-Infecciosos/uso terapêutico , Cefalosporinas/uso terapêutico , Infecções por Clostridium/tratamento farmacológico , Infecção Hospitalar/tratamento farmacológico , Atenção à Saúde , Humanos , Pandemias , Estudos Retrospectivos , Fatores de Risco , Romênia/epidemiologia , SARS-CoV-2 , Centros de Atenção Terciária
2.
Phys Chem Chem Phys ; 17(42): 28322-30, 2015 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-25959221

RESUMO

Thermodynamic properties, thermal expansion and electrical resistivity of the Ag-28% Cu nanopowders processed by the mechanical alloying route have been investigated in the temperature range from ambient to 1048 K. The thermodynamic properties represented by the relative enthalpy, the specific heat capacity, the relative entropy and the Gibbs energy function obtained from drop calorimetric measurements have been used to reveal the occurrence of the micro-relaxation process, as well as of the correlative effects of decomposition and growth processes. On the basis of the results, the parameters that favour stable nanostructured systems in Ag-28% Cu powders synthesized by the mechanical alloying route have been identified. The correlation of the energetic parameters with thermal expansion and electrical resistivity in mechanical alloyed nanocrystalline powders with the eutectic composition is discussed.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...